69 related articles for article (PubMed ID: 15737687)
1. The combination of Jun N-terminal kinase inhibitor and TNP-470 blocks carcinosarcoma-induced endothelial cell tube formation in a synergistic manner.
Miura S; Emoto M; Matsuo Y; Kawarabayashi T; Saku K
Cancer Lett; 2005 Mar; 220(1):49-55. PubMed ID: 15737687
[TBL] [Abstract][Full Text] [Related]
2. Carcinosarcoma-induced endothelial cells tube formation through KDR/Flk-1 is blocked by TNP-470.
Miura S; Emoto M; Matsuo Y; Kawarabayashi T; Saku K
Cancer Lett; 2004 Jan; 203(1):45-50. PubMed ID: 14670616
[TBL] [Abstract][Full Text] [Related]
3. Metronomic doxifluridine chemotherapy combined with the anti-angiogenic agent TNP-470 inhibits the growth of human uterine carcinosarcoma xenografts.
Naganuma Y; Choijamts B; Shirota K; Nakajima K; Ogata S; Miyamoto S; Kawarabayashi T; Emoto M
Cancer Sci; 2011 Aug; 102(8):1545-52. PubMed ID: 21631643
[TBL] [Abstract][Full Text] [Related]
4. TNP-470 inhibits growth and the production of vascular endothelial growth factor of uterine carcinosarcoma cells in vitro.
Emoto M; Ishiguro M; Iwasaki H; Kikuchi M; Kawarabayashi T
Anticancer Res; 2000; 20(1C):601-4. PubMed ID: 10769702
[TBL] [Abstract][Full Text] [Related]
5. Effect of angiogenesis inhibitor TNP-470 on the growth, blood flow, and microvessel density in xenografts of human uterine carcinosarcoma in nude mice.
Emoto M; Ishiguro M; Iwasaki H; Kikuchi M; Kawarabayashi T
Gynecol Oncol; 2003 Apr; 89(1):88-94. PubMed ID: 12694659
[TBL] [Abstract][Full Text] [Related]
6. TNP-470 blockage of VEGF synthesis is dependent on MAPK/COX-2 signaling pathway in PDGF-BB-activated hepatic stellate cells.
Wang YQ; Luk JM; Chu AC; Ikeda K; Man K; Kaneda K; Fan ST
Biochem Biophys Res Commun; 2006 Mar; 341(1):239-44. PubMed ID: 16413500
[TBL] [Abstract][Full Text] [Related]
7. [Inhibitory effects of TNP-470 in combination with 5-fluorouracil on growth of human colon cancer].
Fan YF; Huang ZH; Nie J
Ai Zheng; 2002 Dec; 21(12):1319-23. PubMed ID: 12520739
[TBL] [Abstract][Full Text] [Related]
8. Stress-activated protein kinase/c-Jun N-terminal kinase (JNK) plays a part in endothelin-1-induced vascular endothelial growth factor synthesis in osteoblasts.
Wang X; Tokuda H; Hirade K; Kozawa O
J Cell Biochem; 2002; 87(4):417-23. PubMed ID: 12397601
[TBL] [Abstract][Full Text] [Related]
9. Azaspirene analogs inhibit the growth of human uterine carcinosarcoma in vitro and in vivo.
Emoto M; Yano K; Choijamts B; Sakai S; Hirasawa S; Wakamori S; Aizawa M; Nabeshima K; Tachibana K; Kanomata N
Anticancer Res; 2015 May; 35(5):2739-46. PubMed ID: 25964553
[TBL] [Abstract][Full Text] [Related]
10. Frequent administration of angiogenesis inhibitor TNP-470 (AGM-1470) at an optimal biological dose inhibits tumor growth and metastasis of metastatic human transitional cell carcinoma in the urinary bladder.
Inoue K; Chikazawa M; Fukata S; Yoshikawa C; Shuin T
Clin Cancer Res; 2002 Jul; 8(7):2389-98. PubMed ID: 12114444
[TBL] [Abstract][Full Text] [Related]
11. c-Jun NH2-terminal kinase pathway is involved in constitutive matrix metalloproteinase-1 expression in a hepatocellular carcinoma-derived cell line.
Sugioka Y; Watanabe T; Inagaki Y; Kushida M; Niioka M; Endo H; Higashiyama R; Okazaki I
Int J Cancer; 2004 May; 109(6):867-74. PubMed ID: 15027120
[TBL] [Abstract][Full Text] [Related]
12. Mammalian target of rapamycin pathway promotes tumor-induced angiogenesis in adenoid cystic carcinoma: its suppression by isoliquiritigenin through dual activation of c-Jun NH2-terminal kinase and inhibition of extracellular signal-regulated kinase.
Sun ZJ; Chen G; Zhang W; Hu X; Huang CF; Wang YF; Jia J; Zhao YF
J Pharmacol Exp Ther; 2010 Aug; 334(2):500-12. PubMed ID: 20484154
[TBL] [Abstract][Full Text] [Related]
13. Antitumor effect of TNP-470, an angiogenesis inhibitor, combined with ultrasound irradiation for human uterine sarcoma xenografts evaluated using contrast color Doppler ultrasound.
Emoto M; Tachibana K; Iwasaki H; Kawarabayashi T
Cancer Sci; 2007 Jun; 98(6):929-35. PubMed ID: 17433035
[TBL] [Abstract][Full Text] [Related]
14. IL-1 and TNF induction of matrix metalloproteinase-3 by c-Jun N-terminal kinase in trabecular meshwork.
Hosseini M; Rose AY; Song K; Bohan C; Alexander JP; Kelley MJ; Acott TS
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1469-76. PubMed ID: 16565381
[TBL] [Abstract][Full Text] [Related]
15. Advanced Chemoembolization by Anti-angiogenic Calcium-Phosphate Ceramic Microspheres Targeting the Vascular Heterogeneity of Cancer Xenografts.
Emoto M; Yoshihisa H; Yano K; Choijamts B; Tsugu H; Tachibana K; Aizawa M
Anticancer Res; 2015 Sep; 35(9):4757-64. PubMed ID: 26254366
[TBL] [Abstract][Full Text] [Related]
16. Isoliquiritigenin inhibits migration and invasion of prostate cancer cells: possible mediation by decreased JNK/AP-1 signaling.
Kwon GT; Cho HJ; Chung WY; Park KK; Moon A; Park JH
J Nutr Biochem; 2009 Sep; 20(9):663-76. PubMed ID: 18824345
[TBL] [Abstract][Full Text] [Related]
17. p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells.
Rousseau S; Houle F; Landry J; Huot J
Oncogene; 1997 Oct; 15(18):2169-77. PubMed ID: 9393975
[TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamic-mediated reduction of temozolomide tumor concentrations by the angiogenesis inhibitor TNP-470.
Ma J; Pulfer S; Li S; Chu J; Reed K; Gallo JM
Cancer Res; 2001 Jul; 61(14):5491-8. PubMed ID: 11454697
[TBL] [Abstract][Full Text] [Related]
19. Involvement of SAPK/JNK in prostaglandin E(1)-induced VEGF synthesis in osteoblast-like cells.
Kanno Y; Tokuda H; Nakajima K; Ishisaki A; Shibata T; Numata O; Kozawa O
Mol Cell Endocrinol; 2004 May; 220(1-2):89-95. PubMed ID: 15196703
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of inflammatory corneal angiogenesis by TNP-470.
Joussen AM; Beecken WD; Moromizato Y; Schwartz A; Kirchhof B; Poulaki V
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2510-6. PubMed ID: 11581191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
